Remgro’s Mediclinic deal raises concentration risk ... but may be worth it
MoneywebNOW · Simon Brown
April 1, 202620m 50s
Audio is streamed directly from the publisher (dl.iono.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Zimele Mbanjwa from FNB Wealth and Investments unpacks Remgro’s move to press ahead with the restructuring of its Mediclinic interests. Master Drilling CFO Andre van Deventer talks us through the group’s record revenue, while Dehan Scherman of National Debt Advisors looks at why more than 60% of consumers are running out of money before month-end.